Effects of sarin on the operant behavior of guinea pigs

Neurotoxicology and Teratology

Volumn 27, Issue 6, 2005, Pages 841-853

  Langston, Jeffrey L ^a   Adkins, Angela L ^a   Moran, Anita V ^a   Rockwood, Gary A ^a   DeFord, Michelle S ^a  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

GB; Guinea pigs; Nerve agents; Operant behavior; Progressive ratio; Sarin

Indexed keywords

SARIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIET RESTRICTION; FOOD ANALYSIS; GUINEA PIG; INSTRUMENTAL CONDITIONING; MALE; MAXIMUM TOLERATED DOSE; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; WEIGHT REDUCTION;

ANIMALS; BODY TEMPERATURE; BODY WEIGHT; CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; LETHAL DOSE 50; MALE; SARIN;

ANIMALIA; CAVIA; CAVIA PORCELLUS;

EID: 27844611449     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2005.06.015     Document Type: Article

References (89)

1. C.R. Atchison, R.E. Sheridan, S.M. Duniho, and T.-M. Shih Development of a guinea pig model for low-dose, long-term exposure to organophosphorus nerve agents Toxicol. Mech. Methods 14 2004 183 194
2. H.P. Benschop, and L.P. De Jong Toxicokinetics of soman: species variation and stereospecificity in elimination pathways Neurosci. Biobehav. Rev. 15 1991 73 77
3. G. Bignami, V. Giardini, and M. Scorrano Behaviorally augmented versus other components in organophosphate tolerance: the role of reinforcement and response factors Fundam. Appl. Toxicol. 5 1985 S213 S224
4. D.W. Blick, S.Z. Kerenyi, S. Miller, M.R. Murphy, G.C. Brown, and S.L. Hartgraves Behavioral toxicity of anticholinesterases in primates: chronic pyridostigmine and soman interactions Pharmacol. Biochem. Behav. 38 1991 527 532
5. D.W. Blick, S.A. Miller, G.C. Brown, and M.R. Murphy Behavioral toxicity of anticholinesterases in primates: chronic physostigmine and soman interactions Pharmacol. Biochem. Behav. 45 1993 677 683
6. D.W. Blick, M.R. Murphy, G.C. Brown, and S.L. Hartgraves Primate performance decrements following acute soman exposure: failure of chemical countermeasures Pharmacol. Biochem. Behav. 49 1994 503 510
7. D.W. Blick, M.R. Murphy, G.C. Brown, M.G. Yochmowitz, J.W. Fanton, and S.L. Hartgraves Acute behavioral toxicity of pyridostigmine or soman in primates Toxicol. Appl. Pharm. 126 1994 311 318
8. D.W. Blick, F.R. Weathersby Jr., G.C. Brown, and M.R. Murphy Behavioral toxicity of anticholinesterases in primates: effects of daily repeated soman exposure Pharmacol. Biochem. Behav. 48 1994 643 649
9. H.E. Brezenoff, J. McGee, and N. Hymowitz Effect of soman on schedule-controlled behavior and brain acetylcholinesterase in rats Life Sci. 37 1985 2421 2430
10. H.E. Brezenoff, J. McGee, N. Hymowitz, and A. Walton Inhibition of acetylcholinesterase in the gut inhibits schedule-controlled behavior in the rat Life Sci. 37 1985 49 54
11. M.A. Brown, and K.A. Brix Review of health consequences from high-, intermediate- and low-level exposure to organophosphorus nerve agents J. Appl. Toxicol. 18 1998 393 408
12. J.L. Burchfiel, and F.H. Duffy Organophosphate neurotoxicity: chronic effects of sarin on the electroencephalogram of monkey and man Neurobehav. Toxicol. Teratol. 4 1982 767 778
13. P.J. Bushnell, K.L. Kelly, and T.R. Ward Repeated inhibition of cholinesterase by chlorpyrifos in rats: behavioral, neurochemical and pharmacological indices of tolerance J. Pharmacol. Exp. Ther. 270 1994 15 25
14. P.J. Bushnell, C.N. Pope, and S. Padilla Behavioral and neurochemical effects of acute chlorpyrifos in rats: tolerance to prolonged inhibition of cholinesterase J. Pharmacol. Exp. Ther. 266 1993 1007 1017
15. T.J. Chippendale, G.A. Zawolkow, R.W. Russell, and D.H. Overstreet Tolerance to low acetylcholinesterase levels: modification of behavior without acute behavioral change Psychopharmacologia 26 1972 127 139
16. G. Collier, D. Levitsky, and C. Weinberg Body weight loss as a measure of motivation in thirsty guinea pigs Psychon. Sci. 10 1968 27 28
17. D.A. Cory-Slechta Schedule-controlled behavior in neurotoxicology H. Tilson C. Mitchell Neurotoxicology 1992 Raven Press Ltd. New York 271 294
18. D.A. Cory-Slechta Neurotoxicant-induced changes in schedule-controlled behavior L.W. Chang Principles of Neurotoxicology 1994 Marcel Dekker New York 313 344
19. D.A. Cory-Slechta. Intermittent schedules of reinforcement as toxicological endpoints, in: H.E. Lowndes, K.R. Reuhl (Eds.), Nervous System and Behavioral Toxicology, Pergamon/Elsevier, New York, 1997, pp. 363-377.
20. D.A. CorySlechta Prolonged lead exposure and fixed ratio performance Neurobehav. Toxicol. Teratol. 8 1986 237 244
21. G.D. D'Mello, and E.A. Duffy The acute toxicity of sarin in marmosets (Callithrix jacchus): a behavioral analysis Fundam. Appl. Toxicol. 5 1985 S169 S174
22. D.M. de Groot, E.P. Bierman, P.L. Bruijnzeel, P. Carpentier, B.M. Kulig, G. Lallement, B.P. Melchers, I.H. Philippens, and A.H. van Huygevoort Beneficial effects of TCP on soman intoxication in guinea pigs: seizures, brain damage and learning behaviour J. Appl. Toxicol. 21 2001 S57 S65
23. G.L. Ellman, K.D. Courtney, V. Andres Jr., and R.M. Feather-Stone A new and rapid colorimetric determination of acetylcholinesterase activity Biochem. Pharmacol. 7 1961 88 95
24. F. Fonnum, and S.H. Sterri Factors modifying the toxicity of organophosphorous compounds including soman and sarin Fundam. Appl. Toxicol. 1 1981 143 147
25. F. Fonnum, S.H. Sterri, P. Aas, and H. Johnsen Carboxylesterases, importance for detoxification of organophosphorus anticholinesterases and trichothecenes Fundam. Appl. Toxicol. 5 1985 S29 S38
26. D.L. Frederick, G.E. Schulze, M.P. Gillam, and M.G. Paule Acute effects of physostigmine on complex operant behavior in rhesus monkeys Pharmacol. Biochem. Behav. 50 1995 641 648
27. E.M. Gause, R.J. Hartmann, B.Z. Leal, and I. Geller Neurobehavioral effects of repeated sublethal soman in primates Pharmacol. Biochem. Behav. 23 1985 1003 1012
28. I. Geller, R.J. Hartmann Jr., and E.M. Gause Effects of subchronic administration of soman on acquisition of avoidance-escape behavior by laboratory rats Pharmacol. Biochem. Behav. 23 1985 225 230
29. I. Geller, R.J. Hartmann, E. Moran, B.Z. Leal, R.J. Haines, and E.M. Gause Acute soman effects in the juvenile baboon: effects on a match-to-sample discrimination task and on total blood acetylcholinesterase Pharmacol. Biochem. Behav. 22 1985 961 966
30. J.J. Gordon, L. Leadbeater, and M.P. Maidment The protection of animals against organophosphate poisoning by pretreatment with a carbamate Toxicol. Appl. Pharm. 43 1978 207 216
31. D. Grob, and J.C. Harvey Effects in man of the anticholinesterase compound sarin (isopropyl methyl phosphonofluoridate) J. Clin. Invest. 37 1958 350 368
32. L.W. Harris, J.H. McDonough Jr., D.L. Stitcher, and W.J. Lennox Protection against both lethal and behavioral effects of soman Drug Chem. Toxicol. 7 1984 605 624
33. S.L. Hartgraves, and M.R. Murphy Behavioral effects of low-dose nerve agents S.M. Somani Chemical Warfare Agents 1992 Academic Press Inc. San Diego 125 154
34. E. Hirsch, and G. Collier Effort as determinant of intake and patterns of drinking in the guinea pig Physiol. Behav. 12 1974 647 655
35. D.W. Hobson, R.L. Joiner, and G.S. Dill Pre-Task Pilot Study 87-10: Technicon and COBAS/FARA Analytical Method Comparison for the Determination of Erythrocyte Acetylcholinesterase in the Primate 1988 Battelle Laboratories Columbus, OH
36. W. Hodos Progressive ratio as a measure of reward strength Science 134 1961 943 944
37. T.J. Hudzik, M. Yanek, T. Porrey, J. Evenden, C. Paronis, M. Mastrangelo, C. Ryan, S. Ross, and C. Stenfors Behavioral pharmacology of AR-A000002, a novel, selective 5-hydroxytryptamine(1B) antagonist J. Pharmacol. Exp. Ther. 304 2003 1072 1084
38. S.W. Hulet, J.H. McDonough, and T.M. Shih The dose-response effects of repeated subacute sarin exposure on guinea pigs Pharmacol. Biochem. Behav. 72 2002 835 845
39. N. Hymowitz, H.E. Brezenoff, J. McGee, K. Campbell, and V. Knight Effect of repeated intraperitoneal injections of soman on schedule-controlled behavior in the rat Psychopharmacology (Berl) 86 1985 404 408
40. N. Hymowitz, A. Ploshnick, L. Laemle, and H. Brezenoff Effects of repeated administration of soman on schedule-controlled behavior and brain in the rat Neurotoxicol. Teratol. 12 1990 47 56
41. R.H. Inns, and L. Leadbeater The efficacy of bispyridinium derivatives in the treatment of organophosphonate poisoning in the guinea-pig J. Pharm. Pharmacol. 35 1983 427 433
42. K.M. Jonson, J.G. Lyle, M.J. Edwards, and R.H.C. Penny Problems in behavioural research with the guinea pig: a selective review Anim. Behav. 23 1975 632 639
43. V.G. Laties, and D.A. Cory-Slechta Some problems in interpreting the behavioral effects of lead and methylmercury Neurobehav. Toxicol. 1 Suppl 1 1979 129 135
44. R.C. MacPhail, K.M. Crofton, and L.W. Reiter Use of environmental challenges in behavioral toxicology Fed. Proc. 42 1983 3196 3200
45. D.M. Maxwell The specificity of carboxylesterase protection against the toxicity of organophosphorus compounds Toxicol. Appl. Pharmacol. 114 1992 306 312
46. D.M. Maxwell, and K.M. Brecht The role of carboxylesterase in species variation of oxime protection against soman Neurosci. Biobehav. Rev. 15 1991 135 139
47. D.M. Maxwell, K.M. Brecht, and B.L. O'Neill The effect of carboxylesterase inhibition on interspecies differences in soman toxicity Toxicol. Lett. 39 1987 35 42
48. D.M. Maxwell, D.E. Lenz, W.A. Groff, A. Kaminskis, and H.L. Froehlich The effects of blood flow and detoxification on in vivo cholinesterase inhibition by soman in rats Toxicol. Appl. Pharmacol. 88 1987 66 76
49. J.H. McDonough Performance impacts of nerve agents and their pharmacological countermeasures Mil. Psychol. 14 2002 93 119
50. J.H. McDonough Jr., and T.M. Shih Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology Neurosci. Biobehav. Rev. 21 1997 559 579
51. J.W. McKearney, and J.E. Barrett Schedule-controlled behavior and the effects of drugs D.E. Blackman D.J. Sanger Contemporary Research in Behavioral Pharmacology 1978 Plenum Press New York 1 68
52. B.P. Melchers, I.H. Philippens, and O.L. Wolthuis Efficacy of HI-6 and HLo-7 in preventing incapacitation following nerve agent poisoning Pharmacol. Biochem. Behav. 49 1994 781 788
53. H.E. Modrow, and J.H. McDonough Change in atropine dose effect curve after subacute soman administration Pharmacol. Biochem. Behav. 24 1986 845 848
54. M.C. Newland Motor function and the physical properties of the operant: applications to screening and advanced techniques L.W. Chang W. Slikker Jr. Neurotoxicology: Approaches and Methods 1995 Academic Press New York 265 299
55. D.H. Overstreet, R.W. Russell, B.J. Vasquez, and F.W. Dalglish Involvement of muscarinic and nicotinic receptors in behavioral tolerance to DFP Pharmacol. Biochem. Behav. 2 1974 45 54
56. M.G. Paule Use of the NCTR Operant Test Battery in nonhuman primates Neurotoxicol. Teratol. 12 1990 413 418
57. M.G. Paule, R.R. Allen, J.R. Bailey, A.C. Scallet, S.F. Ali, R.M. Brown, and W. Slikker Jr. Chronic marijuana smoke exposure in the rhesus monkey: II. Effects on progressive ratio and conditioned position responding J. Pharmacol. Exp. Ther. 260 1992 210 222
58. S. Peet, J.D. Shiloff, and J.G. Clement Relationship between age of mice, enzymes such as acetylcholinesterase and aliesterase, and toxicity of soman (pinacolyl methylphosphonofluoridate) Biochem. Pharmacol. 36 1987 3777 3779
59. D.M. Penetar The effects of atropine, benactyzine, and physostigmine on a repeated acquisition baseline in monkeys Psychopharmacology (Berl) 87 1985 69 76
60. D.M. Penetar, and J.H. McDonough Jr. Effects of cholinergic drugs on delayed match-to-sample performance of rhesus monkeys Pharmacol. Biochem. Behav. 19 1983 963 967
61. I.H. Philippens, B.P. Melchers, and O.L. Wolthuis Active avoidance behavior in guinea pigs: effects of physostigmine and scopolamine Pharmacol. Biochem. Behav. 42 1992 285 289
62. I.H. Philippens, O.L. Wolthuis, R.W. Busker, J.P. Langenberg, and B.P. Melchers Side effects of physostigmine as a pretreatment in guinea pigs Pharmacol. Biochem. Behav. 55 1996 99 105
63. I.H. Philippens, B. Olivier, and B.P. Melchers Effects of physostigmine on the startle in guinea pigs: two mechanisms involved Pharmacol. Biochem. Behav. 58 1997 909 913
64. I.H. Philippens, R.W. Busker, O.L. Wolthuis, B. Olivier, P.L. Bruijnzeel, and B.P. Melchers Subchronic physostigmine pretreatment in guinea pigs: effective against soman and without side effects Pharmacol. Biochem. Behav. 59 1998 1061 1067
65. I.H. Philippens, B.P. Melchers, B. Olivier, and P.L. Bruijnzeel Scopolamine augments the efficacy of physostigmine against soman poisoning in guinea pigs Pharmacol. Biochem. Behav. 65 2000 175 182
66. M.A. Prendergast, A.V. Terry Jr., and J.J. Buccafusco Chronic, low-level exposure to diisopropylfluorophosphate causes protracted impairment of spatial navigation learning Psychopharmacology (Berl) 129 1997 183 191
67. M.A. Prendergast, A.V. Terry Jr., and J.J. Buccafusco Effects of chronic, low-level organophosphate exposure on delayed recall, discrimination, and spatial learning in monkeys and rats Neurotoxicol. Teratol. 20 1998 115 122
68. D.C. Rice Introduction to principles and procedures in behavioral testing Psychopharmacol. Bull. 30 1994 593 599
69. J.A. Romano, J.H. McDonough Jr., R. Sheridan, and F.R. Sidell Health effects of low-level exposure to nerve agents S.M. Somani J.A. Romano Jr. Chemical Warfare Agents: Toxicity at Low Levels 2001 CRC Press Boca Raton 1 24
70. R.W. Russell, and D.H. Overstreet Mechanisms underlying sensitivity to organophosphorus anticholinesterase compounds Prog. Neurobiol. 28 1987 97 129
71. R.W. Russell, B.J. Vasquez, D.H. Overstreet, and F.W. Dalglish Consummatory behavior during tolerance to and withdrawal from chronic depression of cholinesterase activity Physiol. Behav. 7 1971 523 528
72. R.W. Russell, B.J. Vasquez, D.H. Overstreet, and F.W. Dalglish Effects of cholinolytic agents on behavior following development of tolerance to low cholinesterase activity Psychopharmacologia 20 1971 32 41
73. R.W. Russell, D.H. Overstreet, C.W. Cotman, V.G. Carson, L. Churchill, F.W. Dalglish, and B.J. Vasquez Experimental tests of hypotheses about neurochemical mechanisms underlying behavioral tolerance to the anticholinesterase, diisopropyl fluorophosphate J. Pharmacol. Exp. Ther. 192 1975 73 85
74. R.W. Russell, R.A. Booth, S.D. Lauretz, C.A. Smith, and D.J. Jenden Behavioral, neurochemical and physiological effects of repeated exposures to subsymptomatic levels of the anticholinesterase, soman Neurobehav. Toxicol. Teratol. 8 1986 675 685
75. T.M. Shih Time course effects of soman on acetylcholine and choline levels in six discrete areas of the rat brain Psychopharmacology (Berl) 78 1982 170 175
76. T.M. Shih, and J.H. McDonough Efficacy of biperiden and atropine as anticonvulsant treatment for organophosphorus nerve agent intoxication Arch. Toxicol. 74 2000 165 172
77. T.M. Shih, D.M. Penetar, J.H. McDonough Jr., J.A. Romano, and J.M. King Age-related differences in soman toxicity and in blood and brain regional cholinesterase activity Brain Res. Bull. 24 1990 429 436
78. W.C. Stebbins, and D.B. Moody Comparative behavioral toxicology Neurobehav. Toxicol. 1 Suppl 1 1979 33 44
79. S.H. Sterri, S. Lyngaas, and F. Fonnum Toxicity of soman after repetitive injection of sublethal doses in rat Acta Pharm. Toxicol. 46 1980 1 7
80. S.H. Sterri, S. Lyngaas, and F. Fonnum Toxicity of soman after repetitive injection of sublethal doses in guinea-pig and mouse Acta Pharm. Toxicol. 49 1981 8 13
81. E.S. Valenstein The effect of reserpine on the conditioned emotional response in the guinea pig J. Exp. Anal. Behav. 2 1959 219 225
82. A. Vallejo-Freire A simple technique for repeated collection of blood samples from guinea pigs Science 114 1951 524 525
83. F. van Haaren, S.C. Haworth, S.M. Bennett, B.A. Cody, J.B. Hoy, J.L. Karlix, and I.R. Tebbett The effects of pyridostigmine bromide, permethrin, and DEET alone, or in combination, on fixed-ratio and fixed-interval behavior in male and female rats Pharmacol. Biochem. Behav. 69 2001 23 33
84. F. van Haaren, S.C. Haworth, S.M. Bennett, and B.A. Cody The effects of pyridostigmine bromide on progressive ratio performance in male and female rats Pharmacol. Biochem. Behav. 68 2001 81 85
85. H.P. van Helden, R.A. Vanwersch, W.C. Kuijpers, H.C. Trap, and I.H. Philippens Low levels of sarin affect the EEG in marmoset monkeys: a pilot study J. Appl. Toxicol. 24 2004 475 483
86. O.L. Wolthuis, R.A. Vanwersch, and H.P. van Helden Residual behavioral incapacitation after therapy of soman intoxication: the effect of a soman simulator Neurobehav. Toxicol. Teratol. 8 1986 127 130
87. O.L. Wolthuis, I.H. Philippens, and R. Vanwersch On the development of behavioral tolerance to organophosphates: III. Behavioral aspects Pharmacol. Biochem. Behav. 35 1990 561 565
88. O.L. Wolthuis, B. Groen, R.W. Busker, and H.P. van Helden Effects of low doses of cholinesterase inhibitors on behavioral performance of robot-tested marmosets Pharmacol. Biochem. Behav. 51 1995 443 456
89. H. Zenick Use of pharmacological challenges to disclose neurobehavioral deficits Fed. Proc. 42 1983 3191 3195